Impact of Methicillin Resistance on Outcomes of Staphylococcus aureus Bacteremia at a U.S. Center, 2023–2024
Open Access
- 2 June 2026
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (6) , ofag354
Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia has historically been associated with worse outcomes than methicillin-susceptible S. aureus (MSSA), but MRSA epidemiology has evolved and contemporary data are mixed. We evaluated whether methicillin resistance is independently associated with S. aureus bacteremia (SAB) outcomes. Methods: We conducted a retrospective cohort study of adults with a first-episode SAB at two academic hospitals from January 17, 2023 to January 16, 2024. The primary outcome of in-hospital mortality/hospice discharge was compared between MRSA and MSSA. Secondary outcomes included intensive care unit (ICU) admission, 7-day readmission, metastatic complications, infective endocarditis, and recurrent bacteremia. Multivariable logistic regression was used to estimate adjusted odds ratios (aORs), with propensity score matching as sensitivity analysis. Results: Among 329 patients with SAB, 140 (42.6%) had MRSA and 189 (57.4%) had MSSA. Compared with MSSA, MRSA was associated with younger age, lower body mass index, higher injection drug use prevalence, more skin and soft tissue sources, and lower illness severity. After covariate adjustment, methicillin resistance was not associated with mortality/hospice discharge (aOR 1.03, 95% CI 0.49–2.12), ICU admission (aOR 1.09, 95% CI 0.61–1.94), 7-day readmission (aOR 1.51, 95% CI 0.51–4.67), metastatic complications (aOR 0.98, 95% CI 0.47–2.05), infective endocarditis (aOR 1.02, 95% CI 0.42–2.45), or recurrent bacteremia (aOR 2.43, 95% CI 0.92–6.76). Findings were consistent in propensity-matched analyses. Conclusions: In this contemporary academic cohort, methicillin resistance was associated with distinct patient characteristics but not worse short-term outcomes. Host factors, illness severity, and infection source may be more important prognostic determinants.Keywords
Funding Information
- T32 training grant (GM-075766)
This publication has 56 references indexed in Scilit:
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesJournal of Clinical Epidemiology, 2008
- Is MRSA more virulent than MSSA?Clinical Microbiology and Infection, 2007
- Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremiaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillin-resistant S aureus bacteremiaAmerican Heart Journal, 2004
- Comparison of Community- and Health Care–Associated Methicillin-Resistant Staphylococcus aureus InfectionJAMA, 2003
- A Prospective Multicenter Study of Staphylococcus aureus BacteremiaMedicine, 2003
- Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐SusceptibleStaphylococcus aureusBacteremia: A Meta‐analysisClinical Infectious Diseases, 2003
- Health Care–Associated Bloodstream Infections in Adults: A Reason To Change the Accepted Definition of Community-Acquired InfectionsAnnals of Internal Medicine, 2002
- Outcome and Attributable Mortality in Critically Ill Patients With Bacteremia Involving Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureusArchives of internal medicine (1960), 2002
- Comorbidity Measures for Use with Administrative DataMedical Care, 1998